U.S. markets open in 2 hours 2 minutes

Itamar Medical Ltd. (ITMR)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
22.62+0.02 (+0.09%)
At close: 4:00PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bearishpattern detected
Price Crosses Moving Average

Price Crosses Moving Average

Previous Close22.60
Open21.82
Bid0.00 x 800
Ask0.00 x 1100
Day's Range21.25 - 22.89
52 Week Range12.68 - 29.00
Volume6,356
Avg. Volume32,090
Market Cap381.093M
Beta (5Y Monthly)0.64
PE Ratio (TTM)N/A
EPS (TTM)-0.90
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est30.92
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
View more
  • MIND CTI Reports First Quarter 2021 Results
    GlobeNewswire

    MIND CTI Reports First Quarter 2021 Results

    YOQNEAM, Israel, May 12, 2021 (GLOBE NEWSWIRE) -- MIND C.T.I. LTD. – (NasdaqGM:MNDO), a leading provider of convergent end-to-end prepaid/postpaid billing and customer care product-based solutions for service providers, unified communications analytics and call accounting solutions for enterprises as well as enterprise messaging solutions, today announced results for its first quarter ended March 31, 2021. The following will summarize our major achievements in the first quarter of 2021 as well as our business. The financial results can be found in the Company News section of our website at http://www.mindcti.com/company/news/ and in our Form 6-K. Financial Highlights Revenues were $6.1 million, compared with $6.0 million in the first quarter of 2020.Operating income was $1.6 million, or 26% of total revenues, compared with $1.3 million, or 22% of total revenues in the first quarter of 2020.Net income was $1.5 million, or $0.07 per share, compared with $1.2 million, or $0.06 per share in the first quarter of 2020.Cash flow from operating activities was $0.6 million, compared with $1.1 million in the first quarter of 2020.Cash position was $17.5 million as of March 31, 2021 (before the dividend distribution of $5.2 million in April 2021). Monica Iancu, MIND CTI CEO, commented: “During five quarters of unprecedented times as a result of the COVID-19 pandemic, we showed resilience and responsiveness. We have successfully operated and completed all different projects’ milestones. We proved to our customers that as always, they can count on us to tirelessly maintain and strengthen their business, under a firm business continuity program, working remotely using secured access. Our markets present a similar challenging behavior for the last few years, but we feel fortified by the diversification of our revenue streams. It is part of our strategy to pursue acquisitions, in order to enhance our market position, and we are actively seeking potential acquisition opportunities. “Our messaging segment was favorably impacted by activities related to COVID-19 and we plan to expand the range of messaging services we offer and the technological vehicles used to deliver them to our customers, hoping to increase the rate of new customer acquisitions.” Revenue Distribution The Americas represented 34%, Europe represented 57% (including the Message Mobile and GTX revenues in Germany that represented 41%) and the rest of the world represented 9% of total revenues. Customer care and billing software totaled $3.1 million, or 51% of total revenues, enterprise messaging and payment solutions were $2.5 million, or 41% of total revenues and enterprise call accounting software totaled $0.6 million, or 8% of total revenues. Licenses totaled $0.8 million, or 13% of total revenues, while maintenance and additional services were $5.3 million, or 87% of total revenues. Licenses were uniquely high this quarter thanks to two customers’ increase in license to support exceptional growth in the number of their subscribers. Dividend DistributionAs previously announced, the Board declared on March 4, 2021 a gross dividend of $0.26 per share with tax being withheld at a rate of 20%. The dividend of approximately $5.2 million, is presented in our balance sheet as of March 31, 2021 among other payables. The net dividend was distributed to our shareholders and withholding taxes were paid in April 2021. Changes in Management TeamMIND also announced today the appointment of a new CFO. Mr. Tal Weiss, (37), joined us as the new CFO in April 2021, replacing Mr. Shoham Shitrit who joined MIND in 2019 and whom we thank for his contribution and wish continued success. Mr. Weiss comes to MIND after serving three years as company controller of a medical technology company – Itamar Medical Ltd. (Nasdaq: ITMR) and four years as a CPA in the Audit High Tech Team at Ernst & Young (Israel). Tal holds a B.A. degree in Accounting and Economics from Haifa University and is a Certified Public Accountant in Israel. Board of Directors UpdateMr. Amnon Neubach has rejoined MIND’s Board of Directors as an independent director and a member of our Board’s committees. Mr. Neubach had served as an external director of our company from 2001 until 2014. He currently serves as Chairman of the Tel-Aviv Stock Exchange Ltd. since 2014 and has served in various privately-held and public companies as a director, a member of executive committees and in some as chairman of the board. Mr. Neubach holds a B.A. degree in Economics and Business Administration and an M.A. degree in Economics, both from Bar Ilan University. AGM UpdateThe Company held its Annual General Meeting of Shareholders on May 11, 2021 and all the proposed resolutions were approved. About MINDMIND CTI Ltd. is a leading provider of convergent end-to-end billing and customer care product-based solutions for service providers, unified communications analytics and call accounting solutions for enterprises as well as enterprise messaging solutions. MIND provides a complete range of billing applications for any business model (license, SaaS, managed service or complete outsourced billing service) for Wireless, Wireline, Cable, IP Services and Quad-play carriers. A global company, with over twenty years of experience in providing solutions to carriers and enterprises, MIND operates from offices in the United States, Romania, Germany and Israel. Cautionary Statement for Purposes of the "Safe Harbor" Provisions of the Private Securities Litigation Reform Act of 1995: All statements other than historical facts included in the foregoing press release regarding the Company's business strategy are "forward-looking statements", including estimations relating to the impact of the COVID-19 pandemic and mitigation measures in connection thereto, expectations of the results of the Company’s business optimization initiative, integration of the company’s acquisitions and its projected outlook and results of operations. These statements are based on management's beliefs and assumptions and on information currently available to management. Forward-looking statements are not guarantees of future performance, and actual results may materially differ. The forward-looking statements involve risks, uncertainties, and assumptions, including, but not limited to, the impact of the COVID-19 pandemic on our customers and economic conditions in our key markets, as well as the risks discussed in the Company's annual report and other filings with the United States Securities Exchange Commission. The Company does not undertake to update any forward-looking information. For more information please contact:Andrea DrayMIND C.T.I. Ltd.Tel: +972-4-993-6666investor@mindcti.com

  • Itamar Medical’s WatchPAT® Technology Featured in Ladenburg Thalmann Healthcare Symposia Call Series
    GlobeNewswire

    Itamar Medical’s WatchPAT® Technology Featured in Ladenburg Thalmann Healthcare Symposia Call Series

    CAESAREA, Israel, May 10, 2021 (GLOBE NEWSWIRE) -- Itamar Medical Ltd. (NASDAQ and TASE: ITMR), a leading medical device and digital health company focused on the integration of sleep apnea management into the cardiac patient care pathway, today announced its WatchPAT® technology was highlighted in a panel discussion on sleep apnea during Ladenburg Thalmann’s Healthcare Symposia Series. Featured Speakers Included:Dr. Omar Burschtin, Director, Sleep Medicine Program at Icahn School of Medicine at Mount SinaiDr. Burschtin has dedicated the last 24 years of his professional life to sleep medicine. He has been responsible for the creation and expansion of the Sleep Fellowship Program at NYU, the growth and accreditation of the NYU Bellevue Sleep Center and the former Sleep Medicine Associates of NYC (SMANYC) Sleep Center. Dr. Dan Bensimhon, Medical Director, Advanced Heart Failure at Cone HealthDr. Bensimhon is a Duke-trained advanced heart failure cardiologist who serves as the Medical Director of the Advanced HF & Mechanical Circulatory Support Program at Cone Health - a 6-Hospital system in central NC. Dan is a member of the Education Committee of the HF Society of America and is on the Board of the Lebauer-Brodie CV Research Foundation. Interested parties may access an archived webcast of the event on the investor section of the Itamar Medical’s website at: www.itamar-medical.com. About Itamar Medical Ltd.Itamar Medical is a medical technology company focused on the development and commercialization of non-invasive medical devices and solutions to aid in the diagnosis of respiratory sleep disorders. Itamar Medical commercializes a digital healthcare platform to facilitate the continuum of care for effective sleep apnea management with a focus on the core sleep, cardiology and direct to consumer markets. Itamar Medical offers a Total Sleep Solution to help physicians provide comprehensive sleep apnea management in a variety of clinical environments to optimize patient care and reduce healthcare system costs. The Company’s key product, WatchPAT, is commercially available within major markets including the U.S., Japan and Europe. Itamar Medical is a public company traded on the Nasdaq and on the Tel Aviv Stock Exchanges, and is based in Caesarea, Israel with U.S. headquarters based in Atlanta, GA. For additional information visit www.itamar-medical.com. Itamar Medical Investor Relations Contact (U.S.)Leigh Salvo Gilmartin GroupPhone: +1-415-937-5412investors@itamar-medical.com

  • Itamar Medical to Report First Quarter Financial Results and Host Conference Call on Wednesday, May 19, 2021
    GlobeNewswire

    Itamar Medical to Report First Quarter Financial Results and Host Conference Call on Wednesday, May 19, 2021

    CAESAREA, Israel, May 05, 2021 (GLOBE NEWSWIRE) -- Itamar Medical Ltd. (NASDAQ and TASE: ITMR), a leading medical device and digital health company focused on the integration of sleep apnea management into the cardiac patient care pathway, announced today that it will report its financial results for the first quarter 2021 before the U.S. market opens on Wednesday, May 19, 2021. The Company will host a conference call that day at 8:00 a.m. Eastern Time, 3:00 p.m. Israel Time to review financial results and provide a corporate update. The call will be hosted by Gilad Glick, President and CEO, and Shy Basson, CFO. To listen live via webcast, please visit https://edge.media-server.com/mmc/p/vemth6m6. To participate via phone, please use the following dial in information:U.S. toll-free: 1-833-519-1272International: 1-914-800-3844Israel toll-free: 1-809-315-362Conference ID: 9398218 Please log in approximately 10 minutes prior to the scheduled start time. The archived webcast will be available in the Events and Presentations section of the Company’s website for at least 60 days following the call. About Itamar Medical Ltd.Itamar Medical is a medical technology company focused on the development and commercialization of non-invasive medical devices and solutions to aid in the diagnosis of respiratory sleep disorders. Itamar Medical commercializes a digital healthcare platform to facilitate the continuum of care for effective sleep apnea management with a focus on the core sleep, cardiology and direct to consumer markets. Itamar Medical offers a Total Sleep Solution to help physicians provide comprehensive sleep apnea management in a variety of clinical environments to optimize patient care and reduce healthcare system costs. The Company’s key product, WatchPAT, is commercially available within major markets including the US, Japan, and Europe. Itamar Medical is a public company traded on the Nasdaq and on the Tel Aviv Stock Exchanges, and is based in Caesarea, Israel with U.S. headquarters based in Atlanta, GA. For additional information, visit www.itamar-medical.com Itamar Medical Investor Relations Contact (U.S.)Leigh Salvo Gilmartin GroupPhone: +1-415-937-5412investors@itamar-medical.com